IL-12 conditioning improves retrovirally mediated transduction efficiency of CD8+ T cells

被引:0
|
作者
K Andrijauskaite
S Suriano
C A Cloud
M Li
P Kesarwani
L S Stefanik
K M Moxley
M L Salem
E Garrett-Mayer
C M Paulos
S Mehrotra
J N Kochenderfer
D J Cole
M P Rubinstein
机构
[1] Medical University of South Carolina,Department of Surgery
[2] Medical University of South Carolina,Department of Microbiology and Immunology
[3] Loyola University Chicago,Immunology and Biotechnology Division
[4] Faculty of Science,Department of Public Health Sciences
[5] Tanta University,undefined
[6] Medical University of South Carolina,undefined
[7] Experimental Transplantation and Immunology Branch ,undefined
[8] National Cancer Institute,undefined
[9] National Institutes of Health,undefined
来源
Cancer Gene Therapy | 2015年 / 22卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The ability to genetically modify T cells is a critical component to many immunotherapeutic strategies and research studies. However, the success of these approaches is often limited by transduction efficiency. As retroviral vectors require cell division for integration, transduction efficiency is dependent on the appropriate activation and culture conditions for T cells. Naive CD8+ T cells, which are quiescent, must be first activated to induce cell division to allow genetic modification. To optimize this process, we activated mouse T cells with a panel of different cytokines, including interleukin-2 (IL-2), IL-4, IL-6, IL-7, IL-12, IL-15 and IL-23, known to act on T cells. After activation, cytokines were removed, and activated T cells were retrovirally transduced. We found that IL-12 preconditioning of mouse T cells greatly enhanced transduction efficiency, while preserving function and expansion potential. We also observed a similar transduction-enhancing effect of IL-12 preconditioning on human T cells. These findings provide a simple method to improve the transduction efficiencies of CD8+ T cells.
引用
收藏
页码:360 / 367
页数:7
相关论文
共 50 条
  • [1] IL-12 conditioning improves retrovirally mediated transduction efficiency of CD8+ T cells
    Andrijauskaite, K.
    Suriano, S.
    Cloud, C. A.
    Li, M.
    Kesarwani, P.
    Stefanik, L. S.
    Moxley, K. M.
    Salem, M. L.
    Garrett-Mayer, E.
    Paulos, C. M.
    Mehrotra, S.
    Kochenderfer, J. N.
    Cole, D. J.
    Rubinstein, M. P.
    CANCER GENE THERAPY, 2015, 22 (07) : 360 - 367
  • [2] Development of CD8+ effector T cells is differentially regulated by IL-18 and IL-12
    Okamoto, I
    Kohno, K
    Tanimoto, T
    Ikegami, H
    Kurimoto, M
    JOURNAL OF IMMUNOLOGY, 1999, 162 (06): : 3202 - 3211
  • [3] Defect of CD8+ memory T cells developed in absence of IL-12 priming for secondary expansion
    Ye, Zhenmin
    Xu, Shulin
    Moyana, Terence
    Yang, Jicheng
    Xiang, Jim
    CELLULAR & MOLECULAR IMMUNOLOGY, 2008, 5 (02) : 147 - 152
  • [4] IL-12 stimulates CTLs to secrete exosomes capable of activating bystander CD8+ T cells
    Lei Li
    Steven M. Jay
    Yan Wang
    Shu-Wei Wu
    Zhengguo Xiao
    Scientific Reports, 7
  • [5] Defect of CD8+ Memory T Cells Developed in Absence of IL-12 Priming for Secondary Expansion
    Zhenmin Ye
    Shulin Xu
    Terence Moyana
    Jicheng Yang
    Jim Xiang
    Cellular & Molecular Immunology, 2008, 5 : 147 - 152
  • [6] IL-12 stimulates CTLs to secrete exosomes capable of activating bystander CD8+ T cells
    Li, Lei
    Jay, Steven M.
    Wang, Yan
    Wu, Shu-Wei
    Xiao, Zhengguo
    SCIENTIFIC REPORTS, 2017, 7
  • [7] An extrafollicular pathway for the generation of effector CD8+ T cells driven by the proinflammatory cytokine, IL-12
    Shah, Suhagi
    Grotenbreg, Gijsbert M.
    Rivera, Amariliz
    Yap, George S.
    ELIFE, 2015, 4
  • [8] IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+ T cells
    Yang, Qianting
    Li, Gang
    Zhu, Yibei
    Liu, Lin
    Chen, Elizabeth
    Turnquist, Heth
    Zhang, Xueguang
    Finn, Olivera J.
    Chen, Xinchun
    Lu, Binfeng
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2011, 41 (11) : 3351 - 3360
  • [9] Brief in vitro IL-12 conditioning of CD8 + T Cells for anticancer adoptive T cell therapy
    Mohamed Labib Salem
    Samar Salman
    Ibrahim O. Barnawi
    Cancer Immunology, Immunotherapy, 2021, 70 : 2751 - 2759
  • [10] Brief in vitro IL-12 conditioning of CD8 +T Cells for anticancer adoptive T cell therapy
    Salem, Mohamed Labib
    Salman, Samar
    Barnawi, Ibrahim O.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (10) : 2751 - 2759